European Economic Area

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update

Retrieved on: 
Tuesday, November 28, 2023

Alvotech and JAMP Pharma also announced the receipt of a marketing authorization in Canada for AVT04.

Key Points: 
  • Alvotech and JAMP Pharma also announced the receipt of a marketing authorization in Canada for AVT04.
  • Product Revenue: Product revenue was $29.8 million for the nine months ended September 30, 2023, compared to $11.1 million for the same nine months of 2022.
  • Income tax benefit: Income tax benefit was $67.1 million for the nine months ended September 30, 2023, compared to $14.8 million for the same nine months of 2022.
  • Alvotech will conduct a business update conference call and live webcast on Wednesday, November 29 at 8:00 am ET (13:00 GMT).

Mintegral Announces Registration to IAB's Europe's Transparency and Consent Framework, Updates SDK

Retrieved on: 
Wednesday, December 20, 2023

Mintegral, Mobvista's programmatic advertising subsidiary, announced today that it has been approved as the latest vendor to join IAB Europe's Transparency and Consent Framework (V2.2 TCF).

Key Points: 
  • Mintegral, Mobvista's programmatic advertising subsidiary, announced today that it has been approved as the latest vendor to join IAB Europe's Transparency and Consent Framework (V2.2 TCF).
  • Mintegral has also launched updated SDKs to support the Google User Messaging Platform (UMP) and ensure compliance with the additional data protection regulations.
  • In addition to integrating with the IAB Transparency and Consent Framework, Mintegral has been issued SOC2 Type 2 and SOC 3 reports.
  • Mintegral has also successfully remained compliant with IAB OM SDK, GDPR, CCPA, and COPPA while receiving ISO/IEC 27001 and ePrivacyseal endorsements.

STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara

Retrieved on: 
Friday, November 10, 2023

Under a strategic partnership begun in 2019, Alvotech is primarily responsible for developing and manufacturing the AVT04 ustekinumab biosimilar.

Key Points: 
  • Under a strategic partnership begun in 2019, Alvotech is primarily responsible for developing and manufacturing the AVT04 ustekinumab biosimilar.
  • STADA holds commercial rights within Europe, where the company already markets six approved biosimilars, including in gastrointestinal, dermatology and rheumatology indications.
  • STADA’s Global Specialty Head, Bryan Kim, commented: “This positive CHMP opinion puts STADA and Alvotech in prime position to improve patient access in the ustekinumab and interleukin inhibitor markets.
  • AVT04 was designed using the Sp2/0 host cell line and is manufactured using a perfusion process, like the reference product Stelara.

BetterUp Achieves Data Privacy Framework Certification

Retrieved on: 
Wednesday, December 13, 2023

BetterUp®, the inventor of virtual professional coaching and global leader in peak performance for enterprises, is now a certified organization under the Data Privacy Framework (DPF) – which includes the EU-U.S. Data Privacy Framework, UK Extension to the EU-US Data Privacy Framework, and the Swiss-U.S. Data Privacy Framework – as set forth by the U.S. Department of Commerce regarding the collection, use, and retention of personal data transferred from the European Economic Area (EEA), United Kingdom and Switzerland, to the United States.

Key Points: 
  • BetterUp®, the inventor of virtual professional coaching and global leader in peak performance for enterprises, is now a certified organization under the Data Privacy Framework (DPF) – which includes the EU-U.S. Data Privacy Framework, UK Extension to the EU-US Data Privacy Framework, and the Swiss-U.S. Data Privacy Framework – as set forth by the U.S. Department of Commerce regarding the collection, use, and retention of personal data transferred from the European Economic Area (EEA), United Kingdom and Switzerland, to the United States.
  • As part of the certification process, BetterUp demonstrated its commitment to uphold DPF principles regarding all personal data received from the aforementioned regions and countries.
  • This certification builds on the company’s existing security program and Privacy Policy , which is in compliance with ISO 27001, General Data Protection Regulation (GDPR), California Consumer Privacy Act (CCPA), and AICPA’s Service Organization Control 2 (SOC 2) Type II reporting requirements.
  • Visit the Data Privacy Framework website to learn more about the program, and view BetterUp’s page on the Data Privacy Framework List to see the scope of BetterUp’s active certification.

Intercontinental Exchange, Inc. Announces Expiration of Exchange Offer for Black Knight InfoServ, LLC’s Outstanding 3.625% Senior Notes due 2028

Retrieved on: 
Monday, December 11, 2023

Intercontinental Exchange, Inc. (NYSE: ICE) (“ICE”) announced today the expiration of the previously announced private exchange offer (the “Exchange Offer”) and related consent solicitation (the “Consent Solicitation”) made by ICE with respect to the 3.625% Senior Notes due 2028 (CUSIP: 092174AA9 / U0921BAA6) (the “BK Notes”) issued by Black Knight InfoServ, LLC, a wholly owned subsidiary of ICE.

Key Points: 
  • Intercontinental Exchange, Inc. (NYSE: ICE) (“ICE”) announced today the expiration of the previously announced private exchange offer (the “Exchange Offer”) and related consent solicitation (the “Consent Solicitation”) made by ICE with respect to the 3.625% Senior Notes due 2028 (CUSIP: 092174AA9 / U0921BAA6) (the “BK Notes”) issued by Black Knight InfoServ, LLC, a wholly owned subsidiary of ICE.
  • The Exchange Offer and Consent Solicitation expired at 5:00 p.m., New York City time, on December 8, 2023 (the “Expiration Date”).
  • No BK Notes will be exchanged by ICE for any notes of ICE, and the BK Notes previously tendered in the Exchange Offer will be promptly returned to the tendering holders.
  • No consideration will be paid or become payable to holders who validly tendered BK Notes in the Exchange Offer.

HF Sinclair Corporation and Holly Energy Partners, L.P. Announce Expiration and Final Results of Exchange Offers and Consent Solicitations for Outstanding Notes of the HEP Issuers

Retrieved on: 
Thursday, November 30, 2023

The settlement date of the Exchange Offers and Consent Solicitations (the “Settlement Date”) is expected to occur on or about December 4, 2023.

Key Points: 
  • The settlement date of the Exchange Offers and Consent Solicitations (the “Settlement Date”) is expected to occur on or about December 4, 2023.
  • Each series of New Notes will have substantially identical interest rate, interest payment dates, maturity date and redemption terms as the corresponding series of HEP Notes.
  • The complete terms and conditions of the Exchange Offers and Consent Solicitations are described in the Exchange Offer Memorandum.
  • Questions concerning the terms of the Exchange Offers or the Consent Solicitations should be directed to the lead dealer managers for the Exchange Offers and the solicitation agents for the Consent Solicitations:

Intercontinental Exchange, Inc. Announces Amendments to Private Exchange Offer and Consent Solicitation for Black Knight InfoServ, LLC’s Outstanding 3.625% Senior Notes Due 2028

Retrieved on: 
Friday, November 24, 2023

The Exchange Offer is being made only to holders of BK Notes who satisfy the eligibility conditions described under “Disclaimer” below.

Key Points: 
  • The Exchange Offer is being made only to holders of BK Notes who satisfy the eligibility conditions described under “Disclaimer” below.
  • King & Co., Inc., the information agent and exchange agent for the Exchange Offer and Consent Solicitation, at (866) 356-7813.
  • The Exchange Offer and Consent Solicitation are being made only pursuant to the Offering Memorandum, as amended hereby.
  • The complete terms and conditions of the Exchange Offer and Consent Solicitation are set forth in the Offering Memorandum, as amended hereby.

KuCoin Unveils KuCard, A Visa Crypto Card Empowering the Future of Payment

Retrieved on: 
Tuesday, November 21, 2023

KuCoin, a top 5 cryptocurrency exchange platform, is empowering the future of payment with the launch of KuCard.

Key Points: 
  • KuCoin, a top 5 cryptocurrency exchange platform, is empowering the future of payment with the launch of KuCard.
  • View the full release here: https://www.businesswire.com/news/home/20231121892685/en/
    KuCoin, a top 5 cryptocurrency exchange platform, is empowering the future of payment with the launch of KuCard.
  • This groundbreaking cryptocurrency debit card seamlessly merges digital assets with traditional banking, giving users the freedom to spend their cryptocurrency anywhere that accepts regular debit cards.
  • "The launch of KuCard represents a significant milestone for both KuCoin and the cryptocurrency industry as a whole, as the daily payment method, the crypto debit card plays a crucial role in accelerating the crypto mass adoption" said Johnny Lyu, CEO at KuCoin.

HF Sinclair Corporation and Holly Energy Partners, L.P. Announce Results of Early Participation in Exchange Offers and Consent Solicitations for Outstanding Notes of the HEP Issuers and Extension of the Early Participation Exchange Consideration

Retrieved on: 
Tuesday, November 14, 2023

Eligible Holders (as defined below) may no longer withdraw tendered HEP Notes or revoke consents, except as required by applicable law.

Key Points: 
  • Eligible Holders (as defined below) may no longer withdraw tendered HEP Notes or revoke consents, except as required by applicable law.
  • Currently, this is the same time and date as the Expiration Date (as defined below) for the Exchange Offers and Consent Solicitations.
  • In addition, HF Sinclair may amend the terms of any Exchange Offer without amending the terms of any other Exchange Offer.
  • Questions concerning the terms of the Exchange Offers or the Consent Solicitations should be directed to the dealer managers for the Exchange Offers and the solicitation agents for the Consent Solicitations:

HF Sinclair Corporation and Holly Energy Partners, L.P. Announce Results of Early Participation in Exchange Offers and Consent Solicitations for Outstanding Notes of the HEP Issuers and Extension of the Early Participation Exchange Consideration

Retrieved on: 
Tuesday, November 14, 2023

Eligible Holders (as defined below) may no longer withdraw tendered HEP Notes or revoke consents, except as required by applicable law.

Key Points: 
  • Eligible Holders (as defined below) may no longer withdraw tendered HEP Notes or revoke consents, except as required by applicable law.
  • Currently, this is the same time and date as the Expiration Date (as defined below) for the Exchange Offers and Consent Solicitations.
  • In addition, HF Sinclair may amend the terms of any Exchange Offer without amending the terms of any other Exchange Offer.
  • Questions concerning the terms of the Exchange Offers or the Consent Solicitations should be directed to the dealer managers for the Exchange Offers and the solicitation agents for the Consent Solicitations: